Despite resubmitting after an initial complete response letter (CRL) due to manufacturing issues, the combination therapy ...

head of Takeda's US business unit. "Takeda is assessing the details of the CRL and evaluating a regulatory path forward," she added.

After hours: March 24 at 6:17:26 PM EDT Loading Chart for CRL ...

As of 10:27:54 GMT. Market open. Loading Chart for CRL.L ...

After hours: March 13 at 6:59:46 p.m. EDT Loading Chart for CRL ...

After hours: March 21 at 5:29:10 PM EDT ...